Fund detail
Baillie Gifford
large-active, growth, lo
Quarters
52
2020-03-31
$92.30B
Positions
224
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.
| # | Issuer | Value ↓ | Weight | Shares | Share Δ | Share Δ % | Prev Weight | First Held | Price | Est. Cost | Unrealized % | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Grifols ADR GRFS | $64.0M | 0.07% | 3,175,697 | +3,175,697 | 2020-03-31 | $20 | ~$20 | +0.00% | |||
| 2 | CyberArk Software Ltd | $30.2M | 0.03% | 352,448 | +352,448 | 2020-03-31 | $86 | ~$86 | +0.00% | |||
| 3 | Deere & Co DE | $13.7M | 0.01% | 99,496 | +99,496 | 2013-06-30 | $138 | ~$81 | +69.97% | |||
| 4 | T. Rowe Price TROW | $10.7M | 0.01% | 110,072 | +110,072 | 2020-03-31 | $98 | ~$98 | +0.00% | |||
| 5 | HUYA ADR HUYA | $7.8M | 0.01% | 460,755 | +460,755 | 2020-03-31 | $17 | ~$17 | +0.00% | |||
| 6 | Menlo Therapeutics Inc MNLOUSD | $349K | 0.00% | 129,971 | +129,971 | 2020-03-31 | $3 | ~$3 | +0.00% | |||
| 7 | 10X Genomics Inc Class A TXG | $99K | 0.00% | 1,589 | +1,589 | 2020-03-31 | $62 | ~$62 | +0.00% | |||
| 8 | BridgeBio Pharma Inc BBIO | $78K | 0.00% | 2,700 | +2,700 | 2020-03-31 | $29 | ~$29 | +0.00% |